¡¾ÕªÒª¡¿ ¡¡¡¡Ð¡ÊóÅßÌ¥¸Éϸ°ûÊÇÒ»ÖÖÈ«ÄܸÉϸ°û£¬¾ßÓÐÌåÄÚÌåÍâÈ«ÄÜ·Ö»¯ÌØÐÔ¡£ÌåÍâÅàÑøÊ±Äܹ»½øÐÐ×ÔÎÒ¸üУ¬¼´Ï¸°ûͨ¹ý¶Ô³Æ·ÖÁÑÔÚά³ÖÈ«ÄÜÐÔ²»¶ªÊ§µÄÇé¿öÏÂϸ°ûÊýÄ¿Ôö¶à¡£È«ÄÜÐÔά³ÖÊܶàÌõÐźÅͨ·µÄµ÷¿Ø£¬ÆäÖÐgp130ÏÂÓεÄJAK-STAT3¼°PI3Kͨ·µÄ»î»¯ÄÜά³ÖÅßÌ¥¸Éϸ°ûµÄ×ÔÎÒ¸üУ¬¶øSHP2-Ras-ERKµÄ¼¤»îÔò´ÙʹÅßÌ¥¸Éϸ°û·Ö»¯¡£ÎÞѪÇåÌõ¼þÏÂBMP4¼¤»îµÄͨ·ÓëJAK-STAT3ÁªºÏ×÷Óÿɱ£³ÖÅßÌ¥¸Éϸ°ûµÄÈ«ÄÜÐÔ¡£´ËÍ⣬WntÐźÅͨ·µÄ»î»¯Ò²²ÎÓë¶ÔÅßÌ¥¸Éϸ°ûµÄ×ÔÎÒ¸üеĵ÷¿Ø¡£×ÜÖ®£¬¶àÖÖÐźÅͨ·ÐγɵÄÍøÂ羫ȷµ÷¿ØÐ¡ÊóÅßÌ¥¸Éϸ°ûµÄ×ÔÎÒ¸üÐÂÓë·Ö»¯¡£±¾ÎÄÖ÷Òª×ÛÊögp130ÔÚСÊóESϸ°ûÔöÖ³¹ý³ÌÖÐ×÷Ó㬰üÀ¨JAK-STAT3ͨ·»î»¯ÒÖÖÆÐ¡ÊóESϸ°û·Ö»¯£¬PI3Kͨ·»î»¯Î¬³ÖESϸ°ûµÄ×ÔÎÒ¸üкÍSHP-2-Rasͨ·»î»¯´Ù½øESϸ°û·Ö»¯£¬ÒÔ¼°ÆäËûÐźÅͨ·¶ÔСÊóESϸ°û×ÔÎÒ¸üеÄÓ°Ï죬°üÀ¨ÎÞѪÇåÌõ¼þÏÂBMPÁªºÏLIFÄÜά³ÖESϸ°ûµÄ¸ß¶È×ÔÎÒ¸üУ¬WntÐźÅͨ·»î»¯´Ù½øESϸ°û×ÔÎÒ¸üС£
¡¾¹Ø¼ü´Ê¡¿ ÅßÌ¥¸Éϸ°û ×ÔÎÒ¸üÐ ÐźÅͨ· È«ÄÜÐÔ
¡¡¡¡Signaling Pathways Regulating Self-renewal of Mouse Embryonic Stem Cells ¡ª¡ª Review
¡¡¡¡¡¡AbstractMouse embryonic stem cells (ES cells) are pluripotent in that they can give rise to almost all the cell types in vitro and in vivo. Also, they can sustain self-renewal in vitro owing to symmetrical mitosis, i.e., only the cell number increases while the daughter cells remain pluripotent. Self-renewal and pluripotency of ES cells are under stringent regulation of several signaling pathways. Activation of either JAK-STAT3 or PI3K, the downstream cascade of gp130, can maintain the self-renewal of ES cells, while phosphorylation of another gp130-related branch, SHP2-Ras-ERK, drives the differentiation. BMP2/4-mediated signaling is capable of suppressing the differentiation of ES cells in collaboration with activated JAK-STAT3 under serum free culture conditions. Other signaling such as Wnt also contributes to the self-renewal of ES cells. Generally, the network, which is composed of various signaling pathways, modulates the self-renewal and differentiation of mouse ES cells precisely. This review focuses on the role of gp130 in proliferation of mouse ES cells including inhibitory effect of JAK-STAT3 pathway activation on differentiation of mouse ES cells, maintenance effect of PI3K pathway activation on self-renewal of ES cells, promotive effect of SHP-2-Ras-ERK pathway activation on differentiation of ES cells, and influence of other signaling pathways on self-renewal of mouse ES cells, including maintenance effect of BMP combination with LIF under serum free culture conditions on self-renewal of ES cells and promotive effect of Wnt pathway activation on self-renewal of ES cells.
¡¡¡¡Key wordsembryonic stem cell£» self-renewal£» signaling pathway£» pluripotency
¡¡¡¡Ð¡ÊóÅßÌ¥·¢Óý¹ý³ÌÖеķֻ¯×îÔç·¢ÉúÓÚÉ£ÝØÅßÍíÆÚ£¬·Ö»¯·¢ÉúºóÅßÌ¥·ÖΪÁ½²¿·Ö£ºÄÚϸ°ûÍÅ(inner cell mass, ICM)ºÍ×ÌÑø²ã(trophoblast)¡£ICMϸ°û¾ßÓÐÈ«ÄÜ·Ö»¯ÌØÐÔ£¬¿É¼ÌÐø·Ö»¯²úÉúÄÚ¡¢Íâ¡¢ÖÐÈý¸öÅß²ãµÄËùÓÐϸ°û£¬²¢×îÖÕÐγÉÍêÕûµÄÅßÌ¥£Û1£Ý£»×ÌÑø²ãÔòΪÅßÌ¥·¢ÓýÌá¹©ÓªÑø¡£Ð¡ÊóÅßÌ¥¸Éϸ°û(embryonic stem cells, ESϸ°û)¼´À´Ô´ÓÚ3.5ÌìµÄICM£Û2£Ý¡£µ±×¢Éäµ½ÔÐÊóÄÒÅßʱ£¬ESϸ°û¾ßÓÐÓëICMϸ°ûÏàËÆµÄÈ«ÄÜ·Ö»¯ÌØÐÔ£Û3£Ý¡£ÌåÍâÅàÑøÊ±£¬ESϸ°û¾ßÓÐ×ÔÎÒ¸üÐÂ(self-renewal)ÄÜÁ¦,¼´Ï¸°û½øÐжԳÆÐÔ·ÖÁÑ£¬±íÏÖΪÊýÄ¿Ôö³¤²¢Î¬³ÖÈ«ÄÜ·Ö»¯ÌØÐÔ£Û4£Ý¡£»ùÓÚÉÏÊöÌØµã£¬ESϸ°û²»½öÊÇ»ùÒò¹¦ÄÜÑо¿µÄÓÐÁ¦¹¤¾ß£¬ ¶øÇÒÆä·Ö»¯Ï¸°ûÔÚÖÎÁÆÌÇÄò²¡ºÍÅÁ½ðɲ¡µÈ¶¯ÎïÄ£ÐÍÉÏҲȡµÃÁ˽ϺõÄЧ¹û£Û5,6£Ý¡£ ÈË ES ϸ°ûÓëСÊóESϸ°û¾ßÓÐÏàËÆµÄÉúÎïÑ§ÌØµã£¬¼´×ÔÎÒ¸üкͶàÏò·Ö»¯£Û4,7,8£Ý¡£ESϸ°ûµÄÅàÑø·Ö»¯ÏµÍ³¼°·Ö×Ó»úÖÆÑо¿ÊÇÆäÓ¦ÓÃÓÚ×éÖ¯¹¤³ÌºÍϸ°ûÖÎÁƵĻù´¡£Û9£Ý£¬Òò¶ø¾ßÓÐÖØÒªÒâÒå¡£ESϸ°ûµÄ×ÔÎÒ¸üÐÂÓ붨Ïò·Ö»¯Êܲ»Í¬ÐźÅͨ·µÄµ÷½Ú£¬¸÷ÐźÅͨ·֮¼äÓÖÏ໥×÷Ó㬹²Í¬µ÷¿ØESϸ°ûµÄÌåÍâÔöÖ³¡£±¾ÎÄÖØµã¾ÍСÊóESϸ°û×ÔÎÒ¸üеĵ÷¿ØÐźŽøÐÐ×ÛÊö¡£
¡¡¡¡gp130ÔÚСÊóESϸ°ûÔöÖ³¹ý³ÌÖеÄ×÷Óý¨ÏµÖ®³õ£¬ÈËÃÇ×¢Ò⵽СÊóESϸ°ûÖ»ÓÐÓëСÊóÅßÌ¥³ÉÏËάϸ°û(mouse embryonic fibroblast, MEF )¹²ÅàÑø²Å¿ÉÒÔά³ÖÆä×ÔÎÒ¸üеÄÌØÐÔ£»ÈôʧȥMEFµÄÖ§³ÖÔòÁ¢¼´·¢Éú·Ö»¯£¬ËµÃ÷MEFÄÜ´Ù½øESϸ°ûÔöÖ³²¢/»òÒÖÖÆÆä·Ö»¯¡£Ö®ºóµÄÑо¿±íÃ÷£ºMEFͨ¹ý·ÖÃÚ°×Ѫ²¡ÒÖÖÆÒò×Ó(leukemia inhibitory factor, LIF)ÒÖÖÆESϸ°ûµÄ·Ö»¯£Û10,11£Ý¡£LIFÊôÓÚIL-6ϸ°ûÒò×Ó¼Ò×壬¸Ã¼Ò×åϸ°ûÒò×ÓÖ÷ÒªÓÐIL-6¡¢IL-11¡¢LIF¡¢CNTF¡¢CT-1¡¢OSMµÈ¡£¸Ã¼Ò×岻ͬϸ°ûÒò×Ó¾ßÓÐÏàͬ»òÏàËÆµÄÉúÎïѧЧӦ¡£ÀýÈ磬OSM£¬CNTF£¬CT-1¼°LIF¶¼ÄÜÒÖÖÆESϸ°û·Ö»¯¡£ESϸ°û²»±í´ïIL-6µÄÊÜÌ壬¹ÊIL-6²»ÄÜÒÖÖÆESϸ°û·Ö»¯£¬µ«µ±IL-6ºÍÆä¿ÉÈÜÐÔÊÜÌ干ͬ×÷ÓÃÓÚESϸ°ûʱ¼´¿ÉÒÔÒÖÖÆESϸ°ûµÄ·Ö»¯£Û12£Ý¡£IL-6¼Ò×岻ͬÒò×Ó¾ßÓÐÏàͬÉúÎïѧЧӦµÄ·Ö×Ó»ù´¡ÊÇËüÃǹ²Í¬µÄÊÜÌågp130£Û13£Ý¡£gp130ÊÇÒ»ÖÖ¿çĤµ°°×£¬Êôϸ°ûÒò×ÓÊÜÌ峬¼Ò×壬±¾ÉíÎÞ¼¤Ã¸»îÐÔ£¬Æä½éµ¼µÄÐźŴ«µÝÒÀÀµÓÚϸ°ûÄÚÒ»ÖÖ·ÇÊÜÌåÐÍÀÒ°±Ëá(Tyr)µ°°×¼¤Ã¸JAK (Janus kinase)¡£gp130ÓëÅä»ù½áºÏÒýÆðϸ°ûÄڵIJ»Í¬JAK·Ö×ÓÖ®¼äµÄ¿¿½üºÍÏ໥Á×Ëữ£¬»î»¯µÄJAK¼Ì¶øÊ¹gp130ÌØ¶¨Î»µãµÄTyr²Ð»ùÁ×Ëữ¡£¼Ì¶ø£¬ÏÂÓÎÐźŷÖ×Ó£¨È磺STAT£¬SHP-2£©ÔòÒÀÀµSH2(Src homology 2)½á¹¹ÓòÓëgp130ÉÏÁ×ËữµÄTyr²Ð»ù½áºÏ£¬¶øJAKÔòÄܹ»Ê¹Óëgp130 ½áºÏµÄ¸ÃÐźŷÖ×ÓÁ×Ëữ¶ø»î»¯£Û14£Ý¡£STAT3 (signal transducer and activator of transcrip- tion) ¼´ÊÇJAKÏÂÓξßÓÐSH2½á¹¹µÄÖ÷ÒªÐźŷÖ×Ó£¬µ±ÆäÓëgp130ÉϵÄÁ×ËữTry½áºÏºó£¬JAK¿ÉÒÔ½«ÆäÁ×Ëữ£¬¼Ì¶ø½øÈëºËÄÚµ÷½ÚÏà¹Ø»ùÒòµÄת¼ºÍ±í´ï¡£³ýJAK-STAT3ͨ·Í⣬gp130»¹¿ÉÒÔ¼¤»îPI3Kͨ·¼°SHP-2-Ras-ERKͨ·¡£ÔÚϸ°ûÒò×ӵĴ̼¤Ï£¬SHP-2ͨ¹ýSH2½á¹¹ÓòÓëgp130ÉÏÁ×ËữµÄTyr²Ð»ù½áºÏ£¬ÔòSHP-2±»Á×Ëữ²¢ÎªÏÂÓεÄÁ¬½Óµ°°×Ìṩ½áºÏλµã£¬¼Ì¶ø»î»¯Ras²¢½øÒ»²½¼¤»îÏÂÓεÄERK¡£ERK»î»¯ºóÖ±½Ó×÷ÓÃÓÚϸ°ûÖʵİзÖ×Ó»ò×ªÒÆµ½Ï¸°ûºËÄÚµ÷½Ú»ùÒòת¼¡£´ËÍ⣬»î»¯µÄRas»¹¿ÉÒÔͨ¹ýPI3KµÄ´ß»¯ÑÇ»ùp110½«PI3K¼¤»î£¬´Ó¶øÊ¹PI3Kͨ·»î»¯£Û15£Ý¡£
¡¡¡¡JAK-STAT3ͨ·»î»¯ÒÖÖÆÐ¡ÊóESϸ°û·Ö»¯
¡¡¡¡µ±LIF×÷ÓÃÓÚСÊóESϸ°ûʱ£¬Ê×ÏÈÓëϸ°ûĤÉϵÄLIFÊÜÌ壨LIFR£©½áºÏÐγɶþ¾ÛÌ壬LIF-LIFR¶þ¾ÛÌåÔÙÓëgp130½áºÏ³ÉΪÈý¾ÛÌå¡£gp130ͨ¹ýÉÏÊö»úÖÆÊ¹JAK-STATͨ·ÖеÄSTAT3»î»¯£Û14£Ý¡£ÌåÍâÅàÑøÊ±£¬STAT3µÄ»î»¯ÊÇСÊóESϸ°û×ÔÎÒ¸üеıØÒªÌõ¼þ£Û16,17£Ý¡£Ñо¿±íÃ÷£¬ÊÜÌågp130ÉÏÓÐ4¸öYXXQÐòÁУ¬¸ÃÐòÁÐÄÚTyrÁ×ËữÊÇSTATÓëÖ®½áºÏµÄ±ØÐèÌõ¼þ¡£gp130ÉÏÕâЩ½áºÏλµãȱʧ»òÍ»±ä£¬Ê¹STAT3²»ÄÜÓëÖ®½áºÏ²¢±»»î»¯£¬ÔòESϸ°ûµÄ×ÔÎÒ¸üв»ÄܼÌÐø¡£½«STAT3µÚ705λTyrλµãÌæ»»ÎªPhe¼´ÐγÉÍ»±äÌåSTAT3F£¬ STAT3F¿ÉÒÔͬÕý³£STAT3¾ºÕùgp130ÉϵĽáºÏλµã£¬ÒÔ¼°Í¬Õý³£STAT3ÐγÉûÓлîÐԵĶþ¾ÛÌ壬´Ó¶øÒÖÖÆSTAT3µÄ»î»¯¡£Òò´Ë£¬ÓëÕý³£µÄESϸ°ûÏà±È½Ï£¬Ð¯´øÓÐSTAT3F»ùÒòµÄESϸ°ûÔÚÅàÑø¹ý³ÌÖиüÒ×·¢Éú·Ö»¯£Û16£Ý¡£Í¬Ñù£¬µ±ÓÃSTAT3µÄ·´Òå¹ÑºËÜÕËáתȾESϸ°û£¬Ï¸°ûÄÚSTAT3±í´ïµÄÁ¿½µµÍÒ²¿É´Ù½øESϸ°û·Ö»¯£Û17£Ý¡£ÉÏÊöÑо¿±íÃ÷£ºSTAT3µÄ»î»¯¿ÉÒÔÒÖÖÆÐ¡ÊóESϸ°ûµÄ·Ö»¯¡£
¡¡¡¡PI3Kͨ·»î»¯Äܹ»Î¬³ÖESϸ°ûµÄ×ÔÎÒ¸üÐÂ
¡¡¡¡×î½üµÄÑо¿±íÃ÷£¬LIF»¹¿ÉÒÔͨ¹ýgp130¼¤»îÁ×Ëἡ´¼-3¼¤Ã¸(phosphoinosidide 3 kinase, PI3K)ͨ·£¬¸Ãͨ·µÄ»î»¯¶ÔСÊóºÍÈËESϸ°ûÈ«ÄÜÐÔµÄά³Ö¶¼·¢»ÓÖØÒª×÷ÓãÛ18,19£Ý¡£PI3K¿ÉÒÔ´ß»¯PI(4,5)P2µÄÁ×ËữÐγÉPI(3,4,5)P3£¬ºóÕßÔò´ÙʹÆäÏÂÓεÄPDK1½«AktÁ×Ëữ¡£AktÁ×Ëữºó×÷ÓÃÓÚÏÂÓε×Îï²¢½øÒ»²½µ÷½Úϸ°û¸÷ÏîÉúÀí»î¶¯¡£µ±LIF×÷ÓÃÓÚСÊóESϸ°ûʱ£¬¿ÉÒÔ¼¤»îPI3Kͨ·ʹϸ°ûÄÚAktÁ×ËữˮƽÉý¸ß£¬ÔöÇ¿ESϸ°ûµÄ×ÔÎÒ¸üв¢¼õÉÙϸ°û·Ö»¯¡£Ïà·´£¬µ±ÓÃPI3KµÄÌØÒìÐÔÒÖÖÆ¼ÁLY294002×è¶Ï¸Ãͨ·£¬»òÓûùÒòÍ»±äµÄ·½·¨Ê¹PI3KµÄ´ß»¯ÑÇ»ùʧ»î£¬ÔòESϸ°ûÄÚAktµÄÁ×Ëữˮƽ½µµÍ£¬Í¬Ê±Ï¸°ûÄÚERKµÄ»î»¯ÔöÇ¿¡£ÔÚÕâÖÖÇé¿öÏ£¬ESϸ°û×ÔÎÒ¸üÐÂϽµ¶ø·Ö»¯Ôö¼Ó£Û18£Ý¡£Êµ¼ÊÉÏ£¬PI3KÐźÅͨ·¶ÔСÊóESϸ°ûµÄÔöÖ³µ÷¿Ø×÷ÓÃ×î³õÊÇÔÚPten»ùÒòÇóýµÄESϸ°ûµÃµ½²ûÃ÷µÄ£Û20£Ý¡£Ö×ÁöÒÖÖÆ·Ö×ÓPTENÊÇÒ»ÖÖÁ×Ëáø£¬¿ÉʹPI(3,4,5)P3È¥Á×Ëữ£¬½ø¶ø¶ÔPI3KÐźÅͨ·Æð¸ºµ÷¿Ø×÷ÓãÛ21£Ý¡£Ñо¿·¢ÏÖ£¬PTEN-/-ESϸ°ûÄÚÓÉÓÚPTENµÄȱʧ£¬Ï¸°ûÄÚPI(3,4,5)P3±£³ÖÔÚ¸ßˮƽ£¬Òò´ËÆäÏÂÓÎÐźŷÖ×ÓAktÒ²Ò»Ö±±£³Ö¸ßˮƽµÄ»î»¯×´Ì¬£¬¹Êϸ°ûÔöÖ³¼ÓËÙ£¬²¢Í¬Ê±°éËæ×Åϸ°ûµòÍöµÄ¼õÉÙ£Û20£Ý¡£
¡¡¡¡SHP-2-Ras-ERKͨ·»î»¯´Ù½øESϸ°û·Ö»¯
¡¡¡¡³ýJAK-STAT3¼°PI3Kͨ·Í⣬SHP-2-Ras-ERKÊÇgp130ÏÂÓεÄÁíÒ»ÌõÖ÷ÒªÐźÅͨ·¡£µ°°×Á×ËáøSHP-2ÊÇgp130ÏÂÓÎÒ»ÖÖº¬ÓÐSH2½á¹¹ÓòµÄÐźŷÖ×Ó£¬Æä½éµ¼Ras-ERKÓëgp130Ö®¼äµÄÁ¬½Ó£¬×îÖÕERKµÄ»î»¯Äܹ»´Ù½øESϸ°û·Ö»¯¡£SHP-2-Ras-ERKͨ·µÄ»î»¯¶ÔESϸ°ûµÄ×ÔÎÒ¸üÐÂÆð¸ºµ÷¿Ø×÷Óã¬Òò´Ë×è¶Ï¸Ãͨ·µÄ»î»¯¿ÉÒÔ´Ù½øESϸ°ûµÄ×ÔÎÒ¸üС£È罫gp130ÊÜÌåÉÏSHP-2½áºÏλµã¼´µÚ118λTyrȱʧ£¬Ê¹SHP-2²»ÄÜÓëgp130½áºÏ£¬´Ó¶ø×è¶ÏÁËÓÉSHP-2½éµ¼µÄgp130ÓëÏÂÓÎÐźŷÖ×ÓÖ®¼äµÄÁ¬½Ó£¬µ±LIF×÷ÓÃÓÚ´øÓиûùÒòÍ»±äµÄESϸ°ûʱ²»Äܼ¤»îRas-ERK£¬²¢Í¬Ê±°éËæÏ¸°ûÄÚSTAT3µÄ»î»¯Ê±¼äÑÓ³¤£Û22£Ý£¬Òò´ËESϸ°ûµÄ×ÔÎÒ¸üÐÂÄÜÁ¦µÃµ½¼ÓÇ¿¡£Í¬Ñùµ±SHP-2ÓëÆäÏÂÓÎRas-ERKÖ®¼äµÄÁ¬½Óµ°°×ȱʧ»òÕßÔÚESϸ°ûÄÚ±í´ïÒÖÖÆÐ͵ÄH-Ras£ÛS17N£Ý¶¼¿É×è¶Ï¸ÃÐźÅͨ·ÏÂÓÎÐźŷÖ×ÓERKµÄ»î»¯£¬ÕâЩ±ä»¯Ò²¿ÉÔöÇ¿ESϸ°ûµÄ×ÔÎÒ¸üУÛ23£Ý¡£Ïà·´£¬ÈôÔÚESϸ°ûÄÚ±í´ï×é³ÉÐͻ»ùÒòH-Ras£ÛG12V£Ýʹ¸Ãͨ·³ÖÐøÐԻ£¬ÔòЯ´øÓиûùÒòµÄESϸ°û×ÔÎÒ¸üв»ÄܼÌÐø£Û23,24£Ý¡£´ËÍ⣬SHP-2-Ras-ERKͨ·×è¶ÏºóESϸ°ûµÄ·Ö»¯³öÏÖÒì³£¡£ÈçSHP-2µ°°×°±»ù¶Ë46µ½110λ°±»ùËáȱʧºó£¬SH2½á¹¹Óò²»ÄÜÓëÏÂÓεÄÁ¬½Óµ°°××÷Ó᣸ûùÒòÍ»±äµÄСÊóESϸ°û²»ÄÜÏòÔìѪϸ°ûºÍ³ÉÏËάϸ°û·Ö»¯£Û25£Ý¡£¶øµ±SHP-2µÄ71-121λ°±»ùËáȱʧºó£¬ESϸ°ûµÄÔìѪ·Ö»¯ÑÓ³Ù²¢¼õÉÙ£Û26£Ý¡£Óɴ˿ɼû£¬SHP-2-Ras-ERKͨ·ÊÇESϸ°ûÕý³£·Ö»¯±ØÐèµÄ£¬Æä»î»¯Äܹ»´Ù½øESϸ°ûµÄ·Ö»¯¡£×ܶøÑÔÖ®£¬µ±LIF×÷ÓÃÓÚESϸ°ûʱ£¬¿ÉÒÔͨ¹ýgp130ͬʱ¼¤»îJAK-STAT3¡¢PI3K¼°SHP-2-Ras-ERKͨ·¡£Ö»ÓÐÈýÕßÖ®¼ä±£³Ö¾«È·µÄƽºâ£¬ÔòESϸ°ûµÄ×ÔÎÒ¸üвÅÄܱ£Ö¤¡£×ÛÉÏËùÊö£¬ESϸ°ûÄÚÒÀÀµgp130µÄÐźÅͨ·¶ÔESϸ°û×ÔÎÒ¸üÐÂÓë·Ö»¯µÄµ÷¿Ø¿ÉÒÔ¹éÄÉΪÏÂͼ¡£
¡¡¡¡ÆäËûÐźÅͨ·¶ÔСÊóESϸ°û×ÔÎÒ¸üеÄÓ°Ïì×î½üµÄÑо¿±íÃ÷£¬³ýLIFÍ⣬ÆäËûÐźÅͨ·£¬Èç¹ÇÐÎ̬·¢Éúµ°°×(bone morphogenetic protein£¬ BMP)¼°Wntͨ·£¬¶ÔESϸ°ûµÄ×ÔÎÒ¸üÐÂÒ²·Ç³£ÖØÒª¡£
¡¡¡¡ÎÞѪÇåÌõ¼þÏÂBMPÁªºÏLIFÄܹ»Î¬³ÖESϸ°ûµÄ¸ß¶È×ÔÎÒ¸üÐÂ
¡¡¡¡ÎÞѪÇåÅàÑøÌåϵÄÚ£¬ÔÚLIF×÷ÓÃÏÂËäÈ»´ó²¿·ÖESϸ°ûÄܹ»Î¬³Ö×ÔÎÒ¸üУ¬µ«ÈÔ»áÓÐÉÙÁ¿Ï¸°û·Ö»¯ÎªÉñ¾Ï¸°û£¬ËµÃ÷LIF²¢²»ÄÜÍêÈ«×è¶ÏСÊóESϸ°ûµÄ·Ö»¯£¬ÐèÒªÓëÆäËûϸ°ûÒò×ÓÁªºÏ×÷ÓÃÀ´Î¬³ÖESϸ°û×ÔÎÒ¸üУ¬ÌرðÊÇÄܹ»ÒÖÖÆESϸ°ûÏòÉñ¾Ï¸°û·Ö»¯µÄÒò×Ó£Û27£Ý¡£¶øBMPÄܹ»ÒÖÖÆESϸ°ûÏòÉñ¾Ï¸°ûµÄ·Ö»¯£¬ÌáʾLIFÓëBMPÁªºÏ×÷ÓÿÉÄÜ»áÍêÈ«×è¶ÏESϸ°û·Ö»¯¡£Ñо¿±íÃ÷£¬BMP4ÓëLIF¹²Í¬×÷ÓÃȷʵ¿ÉÒÔʹESϸ°û±£³Ö¸ß¶ÈµÄ×ÔÎÒ¸üС£Æä×÷ÓûúÖÆÊÇ£¬BMP4/2ͨ¹ý¼¤»îSmadͨ·ÓÕµ¼µ°°×IdµÄ±í´ï£¬IdÒÖÖÆESϸ°ûÏòÉñ¾Ï¸°ûµÄ·Ö»¯£¬Í¬Ê±LIF¼¤»îµÄJAK-STAT3ͨ·ÔòÒÖÖÆESϸ°ûÑØÆäËü·½Ïò·Ö»¯¡£Òò´Ë£¬¶þÕßÁªºÏ×÷ÓÃÓÚESϸ°ûʱ£¬¿ÉÒÔ³¹µ××è¶ÏÆä·Ö»¯£Û28£Ý¡£ÁíÍâµÄÑо¿·¢ÏÖ£¬BMP4»¹¿Éͨ¹ýÒÖÖÆESϸ°ûÄÚERKµÄÁ×Ëữ£Û29£ÝÒÖÖÆESϸ°û·Ö»¯¡£ÈçBurdonµÈ£Û22£ÝËùÊö£¬×è¶ÏERKµÄÁ×Ëữ¿ÉÒÔ´Ù½øESϸ°ûµÄ×ÔÎÒ¸üУ¬´Ë´¦ÓÃERKÉÏÓμ¤Ã¸MEKµÄÒÖÖÆ¼ÁPD98059×÷ÓÃÓÚESϸ°û×è¶ÏERKµÄÁ×Ëữ£¬¿ÉÒԵõ½ÓëBMP4ÏàͬµÄ½á¹û¡£